Compounds > 5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide
Page last updated: 2024-09-03

5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide and Uremia

5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide has been researched along with Uremia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amann, K; Münter, K; Nabokov, AV; Ritz, E; Wagner, J; Wessels, S1

Other Studies

1 other study(ies) available for 5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide and Uremia

ArticleYear
Endothelin receptor antagonists influence cardiovascular morphology in uremic rats.
    Kidney international, 1999, Volume: 55, Issue:2

    Topics: Animals; Arteries; Coronary Vessels; Dansyl Compounds; Endothelin Receptor Antagonists; Heart; Male; Myocardium; Pyrimidines; Rats; Rats, Sprague-Dawley; Sulfonamides; Uremia

1999